Ridgeback Biotherapeutics is a biotechnology company focused on developing treatments and diagnostics for underserved patient populations primarily in pediatric orphan and emerging infectious diseases. The team at Ridgeback is dedicated to working toward finding life-saving and life changing solutions for patients and diseases that need champions.
Headquartered in Miami, Florida, Ridgeback Biotherapeutics is a privately held, majority woman-owned biotechnology company; all funding for Ridgeback Biotherapeutics has originated from Wayne and Wendy Holman; two science driven individuals who invest in technologies that they believe will make the world a better place.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 3480 Main Hwy,
- Phone
- 305-602-5172
- in****@****cap.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ridgebackbio.com
- Keywords
- Infectious Disease, Orphan Drug Products, Pediatric Indications, Biotechnology, Government-sponsored research, Public Health.
- HQ
- Miami, Florida
Ridgeback Biotherapeutics Questions
Ridgeback Biotherapeutics's helpline number is 305-602-5172
Ridgeback Biotherapeutics's website is ridgebackbio.com
Ridgeback Biotherapeutics's LinkedIn profile is https://www.linkedin.com/company/ridgeback-biotherapeutics
Ridgeback Biotherapeutics has
7 employees.
View email and phone details for 7
employees at Ridgeback Biotherapeutics.
Ridgeback Biotherapeutics's industry is
Biotechnology Research
Ridgeback Biotherapeutics's top competitors are
Hcw Biologics,
Xcovery,
Ridgeback Capital Management,
Maze Therapeutics,
Evanoa Bioscience,
Exuma Biotech,
Venn Therapeutics,
Character Biosciences,
Ridgeback Capital,
Sabin Vaccine Institute.
Ridgeback Biotherapeutics's support email address is info@ridgebackcap.com
Ridgeback Biotherapeutics's categories are Biotechnology Research
Ridgeback Biotherapeutics's founding year is 2016
